Details for Patent: 12,653,779
✉ Email this page to a colleague
Which drugs does patent 12,653,779 protect, and when does it expire?
Patent 12,653,779 protects VIZZ and is included in one NDA.
This patent has eighty-two patent family members in twenty-two countries.
Drugs Protected by US Patent 12,653,779
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lenz Therap | VIZZ | aceclidine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 218585-001 | Jul 31, 2025 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | TREATMENT OF PRESBYOPIA | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,653,779
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2014311558 | ⤷ Start Trial | |||
| Australia | 2016280615 | ⤷ Start Trial | |||
| Australia | 2016280616 | ⤷ Start Trial | |||
| Australia | 2019200623 | ⤷ Start Trial | |||
| Brazil | 112017025722 | ⤷ Start Trial | |||
| Brazil | 112017025726 | ⤷ Start Trial | |||
| Canada | 2922802 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
